Age-Related Immunoreactivity Profiles to Diverse Mycobacterial Antigens in BCG-Vaccinated Chinese Population
- PMID: 33584683
- PMCID: PMC7878369
- DOI: 10.3389/fimmu.2020.608220
Age-Related Immunoreactivity Profiles to Diverse Mycobacterial Antigens in BCG-Vaccinated Chinese Population
Abstract
Long-term immunoreactivity to mycobacterial antigens in Bovis Calmette-Guérin (BCG)-vaccinated population is not well investigated. Herein, 361 volunteer healthy donors (HDs) with neonatal BCG vaccination from Shanghai region (China) were enrolled. They were subdivided into ESAT-6/CFP10- (E6C10-) and ESAT-6/CFP10+ (E6C10+) groups based on gamma-interferon release assays (IGRAs). Three mycobacterial antigens, including Rv0934, Rv3006, and Rv3841, were subjected to the determination of immunoreactivity by ELISPOT assay. The immunoreactivities to three mycobacterial antigens were firstly compared among TB patients (N=39), E6C10+ HDs (N=78, 21.61% of HDs) and E6C10- HDs (N=283, 78.39% of HDs). It was revealed that Rv3006 was dominant upon M.tb infection, while Rv3841 was likely to be more responsive upon latent TB infection. In E6C10- population, the immunoreactivity to Rv3841 maintained along with aging, whereas those to Rv3006 and Rv0934 attenuated in E6C10- HDs older than 45 years old. Our study implies the shift of dominant antigens at different infection statuses, providing the clues for the selection of mycobacterial antigens in vaccine development and precision revaccination in the future.
Keywords: BCG vaccination; aging; healthy population; immunoreactive profiles; mycobacterial proteins.
Copyright © 2021 Yang, Zhang, Xiao, Liang, Ji, Wang, Wang and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.Scand J Immunol. 2010 Oct;72(4):349-57. doi: 10.1111/j.1365-3083.2010.02448.x. Scand J Immunol. 2010. PMID: 20883320
-
Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.J Infect. 2019 Apr;78(4):275-280. doi: 10.1016/j.jinf.2018.10.016. Epub 2018 Dec 5. J Infect. 2019. PMID: 30528871
-
Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.Infect Immun. 2007 Jul;75(7):3523-30. doi: 10.1128/IAI.01999-06. Epub 2007 May 14. Infect Immun. 2007. PMID: 17502400 Free PMC article.
-
Interferon gamma release assays: principles and practice.Enferm Infecc Microbiol Clin. 2010 Apr;28(4):245-52. doi: 10.1016/j.eimc.2009.05.012. Epub 2009 Sep 24. Enferm Infecc Microbiol Clin. 2010. PMID: 19783328 Review.
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
Cited by
-
Scientometric analysis of Mycobacterium tuberculosis revaccination: Dynamics, impact and analysis of collaborative networks.Lung India. 2025 Jan 1;42(1):32-39. doi: 10.4103/lungindia.lungindia_433_24. Epub 2024 Dec 24. Lung India. 2025. PMID: 39718913 Free PMC article.
-
Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface.Front Immunol. 2022 Aug 12;13:935573. doi: 10.3389/fimmu.2022.935573. eCollection 2022. Front Immunol. 2022. PMID: 36032096 Free PMC article.
References
-
- WHO Global tuberculosis report 2018. Geneva: World Health Organization; (2018).
-
- National BCG Vaccination Team Push BCG vaccination work one step further. Chin J Antituberc (1957) 05(1000–6621):24–9.
-
- Nguipdop-Djomo P, Heldal E, Laura Cunha R, Ibrahim A, Punam M. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study. Lancet Infect Dis (2016) 16(2):219–26. 10.1016/S1473-3099(15)00400-4 - DOI - PubMed
-
- Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JAC, et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Health Technol Assess (2013) 17(37):1–372, v–vi. 10.3310/hta17370 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical